Atlas Trials

Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block

Clinical trial NCT05158647 · COMPLETED

Trial details

NCT number
NCT05158647
Sponsor
Abdelrady S Ibrahim, MD
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Magnesium Sulfate Causing Adverse Effects in Therapeutic Use
Start date
2018-08-12
Primary completion
2020-02-07
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.